MedTrace Logo

Nigrosomal Iron Imaging in Parkinson's Disease

NCT03022357 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 145

Last updated 2018-10-12

No results posted yet for this study

Summary

Prospective observational study to compare sensitivity of 3T functional Magnetic Resonance Imaging (3T fMRI) at diagnosing Parkinson's Disease (PD) against the benchmark DaTScan diagnostic test and clinical diagnosis at follow up.

Conditions

  • Parkinson Disease

Interventions

OTHER

Patient assessment

Clinical examination, Examination, Questionnaires

RADIATION

DATScan

In small subgroup

RADIATION

Orbital X-Ray

If foreign body in eye needs exclusion

OTHER

Magnetic Resonance Imaging (MRI)

MRI scanning of all subjects

Sponsors & Collaborators

  • Michael J. Fox Foundation for Parkinson's Research

    collaborator OTHER

  • National Institute for Health Research, United Kingdom

    collaborator OTHER_GOV

  • University of Nottingham

    lead OTHER

Principal Investigators

  • Dorothee Auer (Principal Investigator) · University of Nottingham

  • Stefan Schwarz (Co-Principal Investigator) · University of Nottingham

Eligibility

Min Age
21 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2019-04-30
Completion
2019-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03022357 on ClinicalTrials.gov